Claims
- 1. A nucleic acid ligand to transforming growth factor-beta (TGF.beta.) identified according to a method comprising:
- a) preparing a candidate mixture of nucleic acids;
- b) contacting the candidate mixture of nucleic acids with TGF.beta., wherein nucleic acids having an increased affinity to TGF.beta. relative to the candidate mixture may be partitioned from the remainder of the candidate mixture;
- c) partitioning the increased affinity nucleic acids from the remainder of the candidate mixture; and
- d) amplifying the increased affinity nucleic acids to yield a mixture of nucleic acids enriched for nucleic acid sequences with relatively higher affinity and specificity for binding to TGF.beta., whereby said nucleic acid ligand of TGF.beta. may be identified.
- 2. A nucleic acid ligand to transforming growth factor-beta 1 (TFG.beta.1) identified according to a method comprising:
- a) preparing a candidate mixture of nucleic acids;
- b) contacting the candidate mixture of nucleic acids with TGF.beta.1, wherein nucleic acids having an increased affinity to TGF.beta.1 relative to the candidate mixture may be partitioned from the remainder of the candidate mixture;
- c) partitioning the increased affinity nucleic acids from the remainder of the candidate mixture; and
- d) amplifying the increased affinity nucleic acids to yield a mixture of nucleic acids enriched for nucleic acid sequences with relatively higher affinity and specificity for binding to TGF.beta.1, whereby said nucleic acid ligand of TGF.beta.1 may be identified.
- 3. A purified and isolated non-naturally occurring RNA ligand to TGF.beta.1 wherein said ligand is selected from the group consisting of the sequences set forth in Table 3 (SEQ ID NOS: 12-42).
- 4. The nucleic acid ligand of claim 1 wherein in the method, said candidate mixture of nucleic acids is comprised of single stranded nucleic acids.
- 5. The nucleic acid ligand of claim 4 wherein in the method, said single stranded nucleic acids are ribonucleic acids.
- 6. The nucleic acid ligand of claim 4 wherein in the method, said single stranded nucleic acids are deoxyribonucleic acids.
- 7. A purified and isolated non-naturally occurring ssDNA ligand to TGF.beta.1 wherein said ligand is selected from the group consisting of the sequences set forth in Table 6 (SEQ ID NOS: 55-89).
- 8. A purified and isolated non-naturally occurring nucleic acid ligand to transforming growth factor-beta (TGF.beta.).
- 9. A purified and isolated non-naturally occurring nucleic acid ligand to transforming growth factor-beta 1 (TGF.beta.1).
- 10. The nucleic acid ligand of claim 5 wherein in the method, said single stranded nucleic acids are comprised 2'-amino (2'-NH.sub.2) modified ribonucleic acids.
- 11. The nucleic acid ligand of claim 5 wherein in the method, said single stranded nucleic acids are comprised 2'-fluoro (2'-F) modified ribonucleic acids.
RELATED APPLICATIONS
This application is a Continuation-in-Part of U.S. patent application Ser. No. 07/714,131, filed Jun. 10, 1991, entitled Nucleic Acid Ligands now U.S. Pat. No. 5,475,096, U.S. patent application Ser. No. 07/931,473, filed Aug. 17, 1992, entitled Nucleic Acid Ligands, now issued as U.S. Pat. No. 5,270,163, U.S. patent application Ser. No. 07/964,624, filed Oct. 21, 1992, entitled Methods of Producing Nucleic Acid Ligands now U.S. Pat. No. 5,496,938, and U.S. patent application Ser. No. 08/117,991, filed Sep. 8, 1993, entitled High-Affinity Nucleic Acid Ligands Containing Modified Nucleotides now abandoned. U.S. patent application Ser. No. 07/714,131 (Now U.S. Pat. No. 5,475,096 now abandoned is a Continuation-in-Part of U.S. patent application Ser. No. 07/536,428, filed Jun. 11, 1990, entitled Systematic Evolution of Ligands by EXponential Enrichment, now abandoned.
US Referenced Citations (1)
Number |
Name |
Date |
Kind |
5459015 |
Janjic et al. |
Oct 1995 |
|
Foreign Referenced Citations (2)
Number |
Date |
Country |
2 183 661 |
Jun 1987 |
GBX |
WO 8906694 |
Jul 1989 |
WOX |
Non-Patent Literature Citations (17)
Entry |
Arteaga et al. (1993) J. Clin. Invest. 92:2569. |
Arteaga et al. (1990) Cell Growth & Differentiation 1:367. |
Barral et al. (1993) Proc. Natl. Acad. Sci. USA 90:3442. |
Shah et al. (1992) Lancet 339:213. |
Joyce (1989) Gene 82:83. |
Joyce and Inoue (1989) Nucleic Acids Research 17:711. |
Ellington and Szostak (1990) Abstract of papers presented at the 1990 meeting on RNA Processing, Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y, p. 226. |
Kinzler and Vogelstein (1989) Nucleic Acids Research 17:3645. |
Kramer et al. (1974) J. Mol. Biol. 89:719. |
Levisohn and Spiegelman (1969) Proc. Natl. Acad. Sci. USA 63:805. |
Levisohn and Spiegelman (1968) Proc. Natl. Acad. Sci. USA 60:866. |
Oliphant et al. (1989) Mol. Cell. Biol. 9:2944. |
Oliphant and Struhl (1988) Nucleic Acids Research 16:7673. |
Oliphant and Struhl (1987) Methods in Enzymology 155:568. |
Oliphant et al. (1986) Gene 44:177. |
Robertson and Joyce (1990) Nature 344:467. |
Thiesen and Bach (1990) Nucleic Acids Research 18:3203. |
Related Publications (3)
|
Number |
Date |
Country |
|
931473 |
Aug 1992 |
|
|
964624 |
Oct 1992 |
|
|
117991 |
Sep 1993 |
|
Continuations (1)
|
Number |
Date |
Country |
Parent |
536428 |
Jun 1990 |
|
Continuation in Parts (1)
|
Number |
Date |
Country |
Parent |
714131 |
Jun 1991 |
|